Excite Pharma Services is a leading FDA-inspected CRO/CMO specializing in high-quality Chemistry, Manufacturing & Controls (CMC) services for pharmaceutical companies. Founded in 2010, the company initially focused on energy and environmental testing services before pivoting to cater to the pharmaceutical industry in December 2012. The introduction of their expertise in CMC services garnered a positive response in the North American region, resulting in steady growth over the past 4 years. The company's expertise lies in analytical chemistry covering drug substances, drug products, and excipients, with a notable milestone being the opening of a cGMP sterile fill/manufacturing facility in February 2016 at its headquarters in Lee’s Summit, Missouri. This facility, featuring an ISO 5 certified clean room, prioritizes injectable product filling/manufacturing. However, it has the flexibility to accommodate other products under special circumstances. Excite Pharma Services offers a comprehensive range of services including method development, validation & transfer, stability programs, release testing, dissolution, residual solvent analysis, and more. The company's commitment to quality is evident in their emphasis on serving customers with the utmost dedication, recognizing its critical significance in successful drug development. Overall, Excite Pharma Services presents a compelling opportunity for venture capitalists seeking to invest in the pharmaceutical and manufacturing sectors.
There is no investment information
No recent news or press coverage available for Excite Pharma Services.